15
Have your say @brownejacobson 'Arrow' declarations lessons from Fujifilm v AbbVie

Arrow declarations webinar, Mark Daniels, March 2017

Embed Size (px)

Citation preview

Page 1: Arrow declarations webinar, Mark Daniels, March 2017

Have your say @brownejacobson

'Arrow' declarationslessons from Fujifilm v AbbVie

Page 2: Arrow declarations webinar, Mark Daniels, March 2017

Have your say @brownejacobson

'Arrow' declarationslessons from Fujifilm v AbbVie

Connect with Mark

[email protected]

+44 (0)121 237 3993

Page 3: Arrow declarations webinar, Mark Daniels, March 2017

Have your say @brownejacobson

Thank you forjoining todayFollow us on LinkedIn fornews, legal updates, realopinions and training:https://www.linkedin.com/company/technology---cyber-security

Page 4: Arrow declarations webinar, Mark Daniels, March 2017

Have your say @brownejacobson

'Arrow' declarationslessons from Fujifilm v AbbVie

Connect with Mark

[email protected]

+44 (0)121 237 3993

Page 5: Arrow declarations webinar, Mark Daniels, March 2017

Have your say @brownejacobson

The English Patents Court – a forum fordeclaratory relief• an innovative forum• Civil Procedure Rules – CPR

40.20• Messier Dowty v Sabena• Nokia Corp v InterDigital• Arrow Generics v Merck & Co

Ltd

• FSA v Rourke– justice to the Claimant– justice to the Defendant– useful purpose– special reasons

Page 6: Arrow declarations webinar, Mark Daniels, March 2017

Have your say @brownejacobson

Statutory declarations• non-infringement – section

71 Patents Act 1977• invalidity (+ revocation) -

section 74(2) Patents Act1977

Page 7: Arrow declarations webinar, Mark Daniels, March 2017

Have your say @brownejacobson

Court’s inherentjurisdiction under CPR40.20• non-essentiality (and

essentiality) to a technicalstandard (Nokia vInterDigital)

• whether licences offered inrespect of SEPs are FRAND(Unwired Planet v Huawei)

Page 8: Arrow declarations webinar, Mark Daniels, March 2017

Have your say @brownejacobson

Court’s inherentjurisdiction under CPR40.20• that the Defendant’s

product was obvious at thepriority date of a patentapplication (not yetgranted) (Arrow and nowhere for real in FKB)

Page 9: Arrow declarations webinar, Mark Daniels, March 2017

Have your say @brownejacobson

Fujifilm v AbbVie• the background• why it mattered - the

market and the patents• the proceedings• strike out and AbbVie’s

offer

Page 10: Arrow declarations webinar, Mark Daniels, March 2017

Have your say @brownejacobson

The FSA v Rourkeconsiderationsapplied• useful purpose• justice to the Claimants and

the Defendants• any special reasons to grant

or not grant

Page 11: Arrow declarations webinar, Mark Daniels, March 2017

Have your say @brownejacobson

Furtherconsiderations• the opening of floodgates?• expert guidance• the court’s approach to

dosage regimens

Page 12: Arrow declarations webinar, Mark Daniels, March 2017

Have your say @brownejacobson

Connect with Mark

[email protected]

+44 (0)121 237 3993

Keep your questions comingor get in touch if you have a specific query

Page 13: Arrow declarations webinar, Mark Daniels, March 2017

Have your say @brownejacobson

Thank you forjoining todayFollow us on LinkedIn fornews, legal updates, realopinions and training:https://www.linkedin.com/company/technology---cyber-security

Page 14: Arrow declarations webinar, Mark Daniels, March 2017

Have your say @brownejacobson

The cases mentioned today• Fujifilm Kyowa Kirin Biologics Company Ltd, Samsung Bioepsis UK Ltd

and Biogen Idec Ltd (together “FKB”) v AbbVie Biotechnology Ltd[2017] EWHC 395 (Pat)

• Messier Dowty v Sabena [2001] 1 All ER (Lord Woolf MR)• Financial Services Authority v Rourke [2002] CP Rep 14 (Neuberger J)• Nokia Corp v InterDigital Technology Corp [2007] EWHC 3077 (Pat)

(Pumfrey J)• Arrow Generics v Merck & Co Ltd [2007] EWHC 1900 (Pat) (Kitchin J)• Unwired Planet v Huawei [2015] EWHC 1029 (Pat)

Page 15: Arrow declarations webinar, Mark Daniels, March 2017

Have your say @brownejacobson

Connect with Mark

[email protected]

+44 (0)121 237 3993

Keep your questions comingor get in touch if you have a specific query